• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Concert Pharmaceuticals Inc

+ Add to Watchlist

73C:GR

9.695 EUR 2.035 26.57%

As of 07:19:05 ET on 09/16/2014.

Snapshot for Concert Pharmaceuticals Inc (73C)

Open: 9.715 Day's Range: 9.695 - 9.718 Volume: 1,062
Previous Close: 7.660 52wk Range: 5.237 - 10.948 1-Yr Rtn: -

Stock Chart for 73C

No chart data available.
  • 73C:GR 9.695
  • 1D
  • 1M
  • 1Y
7.660
Interactive 73C Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 73C

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.9360
Est. PEG Ratio -
Market Cap (M EUR) 174.64
Shares Outstanding (M) 18.01
30 Day Average Volume 37
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 73C

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 73C

Concert Pharmaceuticals, Inc. is a clinical stage biotechnology company. The Company focuses on the use of deuterium to enhance the effects of approved drugs. Concert Pharmaceuticals offers its products throughout the United States.

Roger D TungPresident/CEO/Co-FounderRyan DawsChief Financial Officer
Nancy StuartChief Operating OfficerIan Robert SilvermanSenior VP/General Counsel
More Company Profile & Key Executives for 73C

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil